Multicenter, randomized phase II trial of GM-CSF (GM) plus ipilimumab (Ipi) versus Ipi alone in metastatic melanoma: E1608.
F. Stephen Hodi
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Research Funding - Bristol-Myers Squibb
Sandra J. Lee
No relevant relationships to disclose
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Uma N. M. Rao
No relevant relationships to disclose
Lisa H. Butterfield
No relevant relationships to disclose
Ahmad A. Tarhini
Consultant or Advisory Role - AstraZeneca; Genentech; Merck; Prometheus
Research Funding - Amgen; Bristol-Myers Squibb; ecog/NIH; Merck; Prometheus
Philip D. Leming
No relevant relationships to disclose
Igor Puzanov
No relevant relationships to disclose
John M. Kirkwood
Consultant or Advisory Role - Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis; Vical
Research Funding - Prometheus